Ablation of paroxysmal and persistent atrial fibrillation: 1-year follow-up through continuous subcutaneous monitoring

Journal of Cardiovascular Electrophysiology

Volumn 22, Issue 4, 2011, Pages 369-375

  Pokushalov, Evgeny ^a   Romanov, Alexander ^a   Corbucci, Giorgio ^b   Artyomenko, Sergey ^a   Turov, Alex ^a   Shirokova, Natalya ^a   Karaskov, Alexander ^a  

^a MESHALKIN NATIONAL MEDICAL RESEARCH CENTER   (Russian Federation)

^b MEDTRONIC BAKKEN RESEARCH CENTER   (Netherlands)

Author keywords

antiarrhythmic; atrial fibrillation; catheter ablation; continuous subcutaneous monitoring; drugs; reveal monitor

Indexed keywords

ADULT; ARTICLE; CATHETER ABLATION; DEVICE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; IMAGE RECONSTRUCTION; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PULMONARY VEIN; TREATMENT OUTCOME;

EID: 79954575072     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2010.01923.x     Document Type: Article

References (28)

1. Allessie M, Ausma, Schotten U,: Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002; 54: 230-246. (Pubitemid 34327903)
2. Haîssaguerre M, Jaîs P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Métayer P, Clémenty J,: Spontaneous initiation of atrial fibrillation by ectopic beats originating in the PVs. N Engl J Med 1998; 339: 659-666.
3. Ernst S, Schlüter M, Ouyang F, Khanedani A, Cappato R, Hebe J, Volkmer M, Antz M, Kuck KH,: Modification of the substrate for maintenance of idiopathic human atrial fibrillation. Circulation 1999; 100: 2085-2092.
4. Oral H, Knight BP, Tada H, Ozaydin M, Chugh A, Hassan S, Scharf C, Lai SW, Greenstein R, Pelosi F Jr,., Strickberger SA, Morady F,: PV isolation for paroxysmal and persistent atrial fibrillation. Circulation 2002; 105: 1077-1081. (Pubitemid 34212617)
5. Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, Haines DE, Haissaguerre M, Iesaka Y, Jackman W, Jais P, Kottkamp H, Kuck KH, Lindsay BD, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Natale A, Pappone C, Prystowsky E, Raviele A, Ruskin JN, Shemin RJ,: HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: Recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 2007; 4: 816-861. (Pubitemid 46850611)
6. Patten M, Maas R, Bauer P, Luderitz B, Sonntag F, Dluzniewski M, Hatala R, Opolski G, Muller HW, Meinertz T,: Suppression of paroxysmal atrial tachyarrhythmias-results of the SOPAT trial. Eur Heart J 2004; 25: 1395-1404. (Pubitemid 39078248)
7. Patten M, Maas R, Karim A, Muller HW, Simonovsky R, Meinertz T,: Event-recorder monitoring in the diagnosis of atrial fibrillation in symptomatic patients: Subanalysis of the SOPAT trial. J Cardiovasc Electrophysiol 2006; 17: 1216-1220. (Pubitemid 44583865)
8. Hindricks G, Piorkowski C, Tanner H, Kobza R, Gerds-Li JH, Carbucicchio C, Kottkamp H,. Perception of atrial fibrillation before and after radiofrequency catheter ablation: Relevance of asymptomatic arrhythmia recurrence. Circulation 2005; 112: 307-313. (Pubitemid 41022070)
9. Senatore G, Stabile G, Bertaglia E, Donnici G, De SA, Zoppo F, Turco P, Pascotto P, Fazzari M,: Role of transtelephonic electrocardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation. J Am Coll Cardiol 2005; 45: 873-876. (Pubitemid 40342813)
10. Pontoppidan J, Nielsen JC, Poulsen SH, Hansen PS,: Symptomatic and asymptomatic atrial fibrillation after pulmonary vein ablation and the impact on quality of life. Pacing Clin Electrophysiol 2009; 32: 717-726.
11. Quirino G, Giammaria M, Corbucci G, Pistelli P, Turri E, Mazza A, Perucca A, Checchinato C, Dalmasso M, Barold SS,: Diagnosis of paroxysmal atrial fibrillation in patients with implanted pacemakers: Relationship to symptoms and other variables. Pacing Clin Electrophysiol 2009; 32: 91-98.
12. Piorkowski C, Kottkamp H, Tanner H, Kobdza R, Cosedis Nielsen J, Arya A, Hindricks G,: Value of different follow-up strategies to assess the efficacy of circumferential pulmonary vein ablation for the curative treatment of atrial fibrillation. J Cardiovasc Electrophysiol. 2005; 16: 1286-1292.
13. Martinek M, Aichinger J, Nesser HJ, Ziegler PD, Purerfellner H,: New insights into long-term follow-up of atrial fibrillation ablation: Full disclosure by an implantable pacemaker device. J Cardiovasc Electrophysiol 2007; 18: 818-823. (Pubitemid 47093079)
14. Hanke T, Charitos EI, Stierle U, Karluss A, Kraatz E, Graf B, Hagemann A, Misfeld M, Sievers HH,: Twenty-four-hour holter monitor follow-up does not provide accurate heart rhythm status after surgical atrial fibrillation ablation therapy up to 12 months experience with a novel permanently implantable heart rhythm monitor device. Circulation 2009; 120 (11 Suppl): S177-S184.
15. Botto GL, Padeletti L, Santini M, Capucci A, Gulizia M, Zolezzi F, Favale S, Molon G, Ricci R, Biffi M, Russo G, Vimercati M, Corbucci G, Boriani G,: Presence and duration of atrial fibrillation detected by continuous monitoring: Crucial implications for the risk of thromboembolic events. J Cardiovasc Electrophysiol 2009; 20: 241-248.
16. Ziegler PD, Koehler JL, Mehra R,: Comparison of continuous versus intermittent monitoring of atrial arrhythmias. Heart Rhythm 2006; 3: 1445-1452. (Pubitemid 44849366)
17. Lee SH, Tai CT, Hsieh MH, Tsai CF, Lin YK, Tsao HM, Yu WC, Huang JL, Ueng KC, Cheng JJ, Ding YA, Chen SA,: Predictors of early and late recurrence of atrial fibrillation after catheter ablation of paroxysmal atrial fibrillation. J Interv Card Electrophysiol 2004; 10: 221-226.
18. Vasamreddy CR, Lickfett L, Jayam VK, Nasir K, Bradley DJ, Eldadah Z, Dickfeld T, Berger R, Calkins H,: Predictors of recurrence following catheter ablation of atrial fibrillation using an irrigated-tip ablation catheter. J Cardiovasc Electrophysiol 2004; 15: 692-697. (Pubitemid 38757176)
19. Jaîs P, Nault I, Wright M, Bevilacqua M, Knecht S, Matsuo S, Lim KT, Sacher F, Deplagne A, Bordachar P, Hocini M, Haîssaguerre M,: Early recurrences after atrial fibrillation ablation: Prognostic value and effect of early reablation. J Cardiovasc Electrophysiol 2008; 19: 599-605.
20. Hindricks G, Pokushalov E, Urban L, Taborsky M, Kuck KH, Lebedev D, Rieger G, Pürerfellner H, on behalf of the XPECT Trial investigators: Performance of a new implantable cardiac monitor in detecting and quantifying atrial fibrillation. Results of the XPECT Trial. Circ Arrhythm Electrophysiol 2010; 3: 141-147.
21. Pokushalov E, Romanov A, Artyomenko S, Turov A, Shugayev P, Shirokova N, Katritsis DG,: Ganglionated plexi ablation for long-standing persistent atrial fibrillation. Europace 2010; 12: 342-346.
22. Pollak WM, Simmons JD, Interian A, Atapattu SA, Castellanos A, Myerburg RJ, Mitrani RD,: Clinical utility of intraatrial pacemaker stored electrograms to diagnose atrial fibrillation and flutter. Pacing Clin Electrophysiol 2001; 24 (Pt I): 424-429. (Pubitemid 32374862)
23. Glotzer TV, Hellkamp AS, Zimmerman J, Sweeney MO, Yee R, Marinchak R, Cook J, Paraschos A, Love J, Radoslovich G, Lee KL, Lamas GA,: Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke. Circulation 2003; 107: 1614-1619.
24. Ricci RP, Quesada A, Almendral J, Arribas F, Wolpert C, Adragao P, Zoni-Berisso M, Navarro X, De Santo T, Grammatico G, Santini M, on behalf of DATAS study Investigators: Dual-chamber implantable cardioverter defibrillators reduce clinical adverse events related to atrial fibrillation when compared with single-chamber defibrillators: A subanalysis of the DATAS trial. Europace 2009; 11: 587-593.
25. Glotzer TV, Daoud EG, Wyse DG, Singer DE, Ezekowitz MD, Hilker C, Miller C, Qi D, Ziegler P,: The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk. The TRENDS Study. Circ Arrhythmia Electrophysiol 2009; 2: 474-480.
26. Hoppe UC, Casares JM, Eiskjær H, Hagemann A, Cleland JGF, Freemantle N, Erdmann E,: Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure circulation. 2006; 114: 18-25.
27. Ip J, Waldo AL, Lip GYH, Rothwell PM, Martin DT, Bersohn MM, Choucair WK, Akar JG, Wathen MS,: Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort: The IMPACT study. Am Heart J 2009; 158: 364-370.e1.
28. Corbucci G, Urban L, Hatala R, Jongen T, De Melis M,: Reliability of atrial fibrillation burden through subcutaneous devices. Europace 2010; 12 (Suppl 1): i162(227-2). Abstract.